BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CytoDyn 

5 Centerpointe Drive
Suite 400
Lake Oswego  Oregon  97035  U.S.A.
Phone: 971-204-0382 Fax: n/a


SEARCH JOBS




Industry
Biotechnology






 Company News
CytoDyn Announces Investor Call To Provide Update On Clinical Development Strategy 3/19/2014 9:06:58 AM    More...
CytoDyn Announces Investor Call To Provide Update On Clinical Development Strategy 3/19/2014 7:26:51 AM    More...
CytoDyn Submits Protocol To FDA For Phase 2b Clinical Study Of PRO 140 For Treatment Substitution In Patients With HIV 2/18/2014 9:59:10 AM    More...
CytoDyn Appoints Denis R. Burger, Ph.D. To Board Of Directors 2/13/2014 10:04:17 AM    More...
CytoDyn To Present At 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference On Monday, February 10, 2014 At 10:00 AM Eastern 2/5/2014 7:53:20 AM    More...
CytoDyn Signs Agreement With Amarex Clinical Research LLC To Prepare Two Phase 2b Clinical Trial Protocols To Explore Two Additional Therapeutic Indications For PRO 140 1/28/2014 9:41:54 AM    More...
CytoDyn Announces FDA Approval Of Patient Screening For Phase 2b Study With Lead Product Candidate PRO 140 For The Treatment Of HIV Type 1 1/8/2014 9:22:48 AM    More...
CytoDyn To Webcast Presentation At Biotech Showcase 2014 In San Francisco On Monday, January 13, At 2:30 PM Pacific 1/8/2014 8:43:55 AM    More...
CytoDyn Submits Phase IIb Protocol for PRO 140 Clinical Trial to FDA 10/31/2013 12:19:47 PM    More...
CytoDyn Appoints David Feigal, M.D., as Chief Medical Officer 10/28/2013 6:25:36 AM    More...
12345678910